These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 17881734)

  • 1. Dystroglycan and protein O-mannosyltransferases 1 and 2 are required to maintain integrity of Drosophila larval muscles.
    Haines N; Seabrooke S; Stewart BA
    Mol Biol Cell; 2007 Dec; 18(12):4721-30. PubMed ID: 17881734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein tyrosine phosphatase 69D is a substrate of protein O-mannosyltransferases 1-2 that is required for the wiring of sensory axons in Drosophila.
    Monagas-Valentin P; Bridger R; Chandel I; Koff M; Novikov B; Schroeder P; Wells L; Panin V
    J Biol Chem; 2023 Mar; 299(3):102890. PubMed ID: 36634851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.
    Zhang P; Hu H
    Glycobiology; 2012 Feb; 22(2):235-47. PubMed ID: 21930648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein O-Mannosyltransferases Affect Sensory Axon Wiring and Dynamic Chirality of Body Posture in the
    Baker R; Nakamura N; Chandel I; Howell B; Lyalin D; Panin VM
    J Neurosci; 2018 Feb; 38(7):1850-1865. PubMed ID: 29167399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The twisted abdomen phenotype of Drosophila POMT1 and POMT2 mutants coincides with their heterophilic protein O-mannosyltransferase activity.
    Ichimiya T; Manya H; Ohmae Y; Yoshida H; Takahashi K; Ueda R; Endo T; Nishihara S
    J Biol Chem; 2004 Oct; 279(41):42638-47. PubMed ID: 15271988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drosophila Dystroglycan is a target of O-mannosyltransferase activity of two protein O-mannosyltransferases, Rotated Abdomen and Twisted.
    Nakamura N; Stalnaker SH; Lyalin D; Lavrova O; Wells L; Panin VM
    Glycobiology; 2010 Mar; 20(3):381-94. PubMed ID: 19969597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian
    Larsen ISB; Narimatsu Y; Joshi HJ; Yang Z; Harrison OJ; Brasch J; Shapiro L; Honig B; Vakhrushev SY; Clausen H; Halim A
    J Biol Chem; 2017 Jul; 292(27):11586-11598. PubMed ID: 28512129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A fourth case of POMT2-related limb girdle muscle dystrophy with mild reduction of α-dystroglycan glycosylation.
    Saredi S; Gibertini S; Ardissone A; Fusco I; Zanotti S; Blasevich F; Morandi L; Moroni I; Mora M
    Eur J Paediatr Neurol; 2014 May; 18(3):404-8. PubMed ID: 24183756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synaptic defects in a Drosophila model of congenital muscular dystrophy.
    Wairkar YP; Fradkin LG; Noordermeer JN; DiAntonio A
    J Neurosci; 2008 Apr; 28(14):3781-9. PubMed ID: 18385336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurexin facilitates glycosylation of Dystroglycan to sustain muscle architecture and function in Drosophila.
    Zhao Y; Geng J; Meng Z; Sun Y; Ou M; Xu L; Li M; Gan G; Rui M; Han J; Xie W
    Commun Biol; 2024 Nov; 7(1):1481. PubMed ID: 39521920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. POMT2 mutations cause alpha-dystroglycan hypoglycosylation and Walker-Warburg syndrome.
    van Reeuwijk J; Janssen M; van den Elzen C; Beltran-Valero de Bernabé D; Sabatelli P; Merlini L; Boon M; Scheffer H; Brockington M; Muntoni F; Huynen MA; Verrips A; Walsh CA; Barth PG; Brunner HG; van Bokhoven H
    J Med Genet; 2005 Dec; 42(12):907-12. PubMed ID: 15894594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conditional knockout of protein O-mannosyltransferase 2 reveals tissue-specific roles of O-mannosyl glycosylation in brain development.
    Hu H; Li J; Gagen CS; Gray NW; Zhang Z; Qi Y; Zhang P
    J Comp Neurol; 2011 May; 519(7):1320-37. PubMed ID: 21452199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of enzyme activity and clinical phenotype in POMT1-associated dystroglycanopathies.
    Lommel M; Cirak S; Willer T; Hermann R; Uyanik G; van Bokhoven H; Körner C; Voit T; Barić I; Hehr U; Strahl S
    Neurology; 2010 Jan; 74(2):157-64. PubMed ID: 20065251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the POMT1 gene found in patients with Walker-Warburg syndrome lead to a defect of protein O-mannosylation.
    Akasaka-Manya K; Manya H; Endo T
    Biochem Biophys Res Commun; 2004 Dec; 325(1):75-9. PubMed ID: 15522202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
    Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
    Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. POMT1 is essential for protein O-mannosylation in mammals.
    Lommel M; Willer T; Cruces J; Strahl S
    Methods Enzymol; 2010; 479():323-42. PubMed ID: 20816174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan.
    Carss KJ; Stevens E; Foley AR; Cirak S; Riemersma M; Torelli S; Hoischen A; Willer T; van Scherpenzeel M; Moore SA; Messina S; Bertini E; Bönnemann CG; Abdenur JE; Grosmann CM; Kesari A; Punetha J; Quinlivan R; Waddell LB; Young HK; Wraige E; Yau S; Brodd L; Feng L; Sewry C; MacArthur DG; North KN; Hoffman E; Stemple DL; Hurles ME; van Bokhoven H; Campbell KP; Lefeber DJ; ; Lin YY; Muntoni F
    Am J Hum Genet; 2013 Jul; 93(1):29-41. PubMed ID: 23768512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High throughput screening for compounds that alter muscle cell glycosylation identifies new role for N-glycans in regulating sarcolemmal protein abundance and laminin binding.
    Cabrera PV; Pang M; Marshall JL; Kung R; Nelson SF; Stalnaker SH; Wells L; Crosbie-Watson RH; Baum LG
    J Biol Chem; 2012 Jun; 287(27):22759-70. PubMed ID: 22570487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscle dystroglycan organizes the postsynapse and regulates presynaptic neurotransmitter release at the Drosophila neuromuscular junction.
    Bogdanik L; Framery B; Frölich A; Franco B; Mornet D; Bockaert J; Sigrist SJ; Grau Y; Parmentier ML
    PLoS One; 2008 Apr; 3(4):e2084. PubMed ID: 18446215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of the muscle-specific dystroglycan interactome reveals the role of Hippo signaling in muscular dystrophy and age-dependent muscle atrophy.
    Yatsenko AS; Kucherenko MM; Xie Y; Aweida D; Urlaub H; Scheibe RJ; Cohen S; Shcherbata HR
    BMC Med; 2020 Jan; 18(1):8. PubMed ID: 31959160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.